Sofinnova Investments, Inc. Vir Biotechnology, Inc. Put Options Transaction History

Sofinnova Investments, Inc.

  • $1.23 Billion
  • Q4 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$23.2 - $27.29 $6.96 Million - $8.19 Million
300,000 New
300,000 $7.36 Million
Q1 2022

May 16, 2022
SELL
$21.19 - $40.01 $4.24 Million - $8 Million
-200,000 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$30.97 - $54.03 $6.19 Million - $10.8 Million
200,000 New
200,000 $8.37 Million

Others Institutions Holding VIR

# of Institutions
228
Shares Held
88.4M
Call Options Held
571K
Put Options Held
216K
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.28B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email